Rostrum’s Efforts to address COVID-19 challenges: As the world is facing unprecedented changes and challenges, Rostrum supports all affected individuals during this challenging time. The Rostrum team has been closely monitoring the consistently developing situation surrounding the outbreak of COVID-19. Further to Rostrum’s update in August 2019, Rostrum is pleased to announce its progress on…
Toronto, ON and Vancouver, BC Canada – November 29, 2017 – Thornhill and Rostrum celebrate the finalization of a Technology Development Agreement which includes the licensing of certain Thornhill IP and an investment by Rostrum into Thornhill. This agreement is aimed to further Rostrum’s development of its Pulmonary Health Monitoring during ventilation, in ICU, OR…
Rostrum Medical Innovations Inc., a Canadian medical device developer announced that it has completed its ‘Series A’ offering being fully subscribed by Yonghua Investment Management Co., Ltd. (“Yonghua Capital”) of Shanghai, PRC. August2016-RostrumCompletes